Order Article Reprints

Wang I-H, Huang T-T, Chen J-L, Chu L-W, Ping Y-H, Hsu K-W, Huang K-H, Fang W-L, Lee H-C, Chen C-F, et al. Mevalonate Pathway Enzyme HMGCS1 Contributes to Gastric Cancer Progression. Cancers. 2020; 12(5):1088. https://doi.org/10.3390/cancers12051088

Wang, I-Han, Tzu-Ting Huang, Ji-Lin Chen, Li-Wei Chu, Yueh-Hsin Ping, Kai-Wen Hsu, Kuo-Hung Huang, Wen-Liang Fang, Hsin-Chen Lee, Chian-Feng Chen, and et al. 2020. "Mevalonate Pathway Enzyme HMGCS1 Contributes to Gastric Cancer Progression" Cancers 12, no. 5: 1088. https://doi.org/10.3390/cancers12051088

Wang, I.-H., Huang, T.-T., Chen, J.-L., Chu, L.-W., Ping, Y.-H., Hsu, K.-W., Huang, K.-H., Fang, W.-L., Lee, H.-C., Chen, C.-F., Liao, C.-C., Hsieh, R.-H., & Yeh, T.-S. (2020). Mevalonate Pathway Enzyme HMGCS1 Contributes to Gastric Cancer Progression. Cancers, 12(5), 1088. https://doi.org/10.3390/cancers12051088